These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26340869)

  • 41. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice.
    Hoffmann K; Lindner M; Gröticke I; Stangel M; Löscher W
    Exp Neurol; 2008 Apr; 210(2):308-21. PubMed ID: 18096162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal oxidative metabolism in the cuprizone mouse model of demyelination: An in vivo NIRS-MRI study.
    Hashem M; Shafqat Q; Wu Y; Rho JM; Dunn JF
    Neuroimage; 2022 Apr; 250():118935. PubMed ID: 35091079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
    Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia.
    Jaehne EJ; Corrigan F; Toben C; Jawahar MC; Baune BT
    Pharmacol Biochem Behav; 2015 Aug; 135():136-44. PubMed ID: 26047769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system.
    Herder V; Hansmann F; Stangel M; Skripuletz T; Baumgärtner W; Beineke A
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):676-84. PubMed ID: 21366663
    [No Abstract]   [Full Text] [Related]  

  • 46. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone.
    Xu H; Yang HJ; Zhang Y; Clough R; Browning R; Li XM
    Behav Neurosci; 2009 Apr; 123(2):418-29. PubMed ID: 19331464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice.
    Copray JC; Küst BM; Mantingh-Otter I; Boddeke HW
    Neuropathol Appl Neurobiol; 2005 Dec; 31(6):600-9. PubMed ID: 16281908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
    Pfeifenbring S; Nessler S; Wegner C; Stadelmann C; Brück W
    J Neuropathol Exp Neurol; 2015 Aug; 74(8):756-66. PubMed ID: 26115190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination.
    Millet V; Marder M; Pasquini LA
    Exp Neurol; 2012 Jan; 233(1):490-504. PubMed ID: 22155618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.
    Xiao L; Xu H; Zhang Y; Wei Z; He J; Jiang W; Li X; Dyck LE; Devon RM; Deng Y; Li XM
    Mol Psychiatry; 2008 Jul; 13(7):697-708. PubMed ID: 17684494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
    Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
    Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
    Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
    Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination.
    Torkildsen Ø; Brunborg LA; Milde AM; Mørk SJ; Myhr KM; Bø L
    Clin Nutr; 2009 Feb; 28(1):83-7. PubMed ID: 19042061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice.
    Yamamoto S; Gotoh M; Kawamura Y; Yamashina K; Yagishita S; Awaji T; Tanaka M; Maruyama K; Murakami-Murofushi K; Yoshikawa K
    Eur J Pharmacol; 2014 Oct; 741():17-24. PubMed ID: 25084219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased central dopaminergic activity might be involved in the behavioral abnormality of cuprizone exposure mice.
    Chang H; Liu J; Zhang Y; Wang F; Wu Y; Zhang L; Ai H; Chen G; Yin L
    Behav Brain Res; 2017 Jul; 331():143-150. PubMed ID: 28549646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
    Clarner T; Parabucki A; Beyer C; Kipp M
    J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cuprizone-induced demyelination in CNP::GFP transgenic mice.
    Silvestroff L; Bartucci S; Soto E; Gallo V; Pasquini J; Franco P
    J Comp Neurol; 2010 Jun; 518(12):2261-83. PubMed ID: 20437527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential Susceptibility and Vulnerability of Brain Cells in C57BL/6 Mouse to Mitochondrial Dysfunction Induced by Short-Term Cuprizone Exposure.
    Luo M; Deng M; Yu Z; Zhang Y; Xu S; Hu S; Xu H
    Front Neuroanat; 2020; 14():30. PubMed ID: 32581731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long lasting behavioural effects on cuprizone fed mice after neurotoxicant withdrawal.
    Tomas-Roig J; Torrente M; Cabré M; Vilella E; Colomina MT
    Behav Brain Res; 2019 May; 363():38-44. PubMed ID: 30703396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demyelination of the hippocampus is prominent in the cuprizone model.
    Koutsoudaki PN; Skripuletz T; Gudi V; Moharregh-Khiabani D; Hildebrandt H; Trebst C; Stangel M
    Neurosci Lett; 2009 Feb; 451(1):83-8. PubMed ID: 19084049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.